Chemocentryx reported $4M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 35705M 305M
AstraZeneca AZN:LN 2229663.86M 36335.94M
Bayer BAYN:GR € 38061M 1413M
Biogen BIIB:US $ 6277.4M 1.7M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bristol Myers Squibb BMY:US $ 37107M 343M
Chemocentryx CCXI:US $ 4M 0.55M
GlaxoSmithKline GSK:LN 1878400M 1044200M
Glaxosmithkline GSK:US $ 18784M 10442M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 23784M 589M
Omeros OMER:US $ 314.36M 454K
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Takeda 4502:JP Y 4320357M 178939M
Teva Pharmaceutical TEVA:IT 20.36B 477M
YTE INCY:US $ 31.16M 0.23M